ERNA vs ICE · P/E 0.0, rev $582.0K vs P/E 37, rev $12.64B
Eterna Therapeutics Inc (ERNA) versus Intercontinental Exchange Inc (ICE) — a side-by-side from cached financials, not a winner call.
Eterna Therapeutics Inc (ERNA) is a biotechnology company listed on NASDAQ.
Intercontinental Exchange Inc (ICE) is a financial data & stock exchanges company listed on US.
Latest reported ERNA revenue for 2024-12-31 was $582.0K. Net income was -$44.5M. Revenue was up 755.9% from 2023-12-31 to 2024-12-31. ERNA currently screens at market cap $6.9M and trailing P/E 0.0.
Latest reported ICE revenue for 2025-12-31 was $12.64B. Net income was $3.31B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
ERNA currently screens at market cap $6.9M and trailing P/E 0.0. ICE currently screens at market cap $103.55B and trailing P/E 37.3.
Not investment advice. Open the ERNA and ICE stock pages for the full models.
Not investment advice.